Akèy › Kansè ovè › Ohio › Toledo
Etid klinik pou Kansè ovè nan Toledo, OH
12 etid pou Kansè ovè ap chèche patisipan nan sit nan ak bò kote Toledo (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Ap rekriteFaz 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi lwen
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Ap rekriteFaz 1
- Site 06, Maumee · 9 mi lwen
DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
- Research Site, Maumee · 9 mi lwen
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ap rekriteFaz 3
- ProMedica Flower Hospital, Sylvania · 9 mi lwen
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Ap rekriteFaz 3
- Promedica Flower Hospital, Sylvania · 9 mi lwen
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Ap rekriteEtid obsèvasyon
- Toledo Clinic Cancer Center, Toledo
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Ap rekriteFaz 3
- ProMedica Flower Hospital, Sylvania · 9 mi lwen
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Ap rekriteFaz 1
- Normunity Investigational Site, Maumee · 9 mi lwen
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ap rekrite
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
- ProMedica Flower Hospital, Sylvania · 9 mi lwen
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
- ProMedica Flower Hospital, Sylvania · 9 mi lwen
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Taylor Cancer Research Center, Maumee · 9 mi lwen
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
- Taylor Cancer Research Center, Maumee · 9 mi lwen
Etid Kansè ovè nan lòt vil
- Houston, TX89 etid
- New York City, NY69 etid
- Boston, MA61 etid
- Los Angeles, CA50 etid
- Nashville, TN49 etid
- Arlington, VA46 etid
- Philadelphia, PA44 etid
- Columbus, OH39 etid
- St. Louis, MO38 etid
- Chicago, IL36 etid
- San Antonio, TX31 etid
- Cleveland, OH30 etid
Lòt etid nan Toledo
- Kansè Poumon ki pa ti selil17 etid
- Kansè poumon11 etid
- Kansè Metastatik10 etid
- Akidan serebavaskilè9 etid
- Kansè Endomèt8 etid
- Melanom8 etid
- Kansè pankreyas8 etid
- Karsinòm selil skuamèz tèt ak kou8 etid
- Kansè Ezofajyen7 etid
- Kansè pwostat7 etid
- Ensifizyans kadyak7 etid
- Kansè kolorektal7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.